Literature DB >> 16883126

Regional referral system for patients with acute mechanical support: experience at the Cleveland Clinic Foundation.

Gonzalo V Gonzalez-Stawinski1, Albert S Y Chang, Jose L Navia, Michael K Banbury, Tiffany Buda, Kathy Hoercher, Randall C Starling, David O Taylor, Nicholas G Smedira.   

Abstract

Regional referral networks ("hub and spoke") have been created to facilitate the transfer of patients on mechanical circulatory support. Although individual centers report good success, overall outcomes have remained poor. We investigated whether preoperative variables influenced survival and could be used to help select patients best served by referral. A retrospective chart review was conducted on all patients transferred to our institution supported on cardiac assist devices. Between January 1995 and September 2003, 39 patients were received in transfer for continued care after the implantation of a cardiac assist device. Eighty-five percent of patients had the ABIOMED BVS 5000 implanted. The most common indication was postcardiotomy shock. Sixty-four percent of patients were not candidates for heart transplantation due to medical or social contraindications. The 30-day mortality of this group was 62%. Survivors had less comorbidity and were less likely to have complex surgeries, neurologic impairment, and multisystem organ failure when presenting to our center. Devices were weaned in 30% of cases. Only six patients (15%) were successfully transplanted, and five of these patients have done well at follow-up. Based on our experience, we believe that cardiogenic shock patients benefit from a regional referral system if they have not had complex cardiac surgical procedures or developed multisystem organ failure. Furthermore, there is a survival advantage when using long-term devices because this allows possible recovery or transplantation.

Entities:  

Mesh:

Year:  2006        PMID: 16883126     DOI: 10.1097/01.mat.0000225265.11371.ed

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  5 in total

1.  Interhospital Facility Transfers in the United States: A Nationwide Outcomes Study.

Authors:  Tina Hernandez-Boussard; Sheryl Davies; Kathryn McDonald; N Ewen Wang
Journal:  J Patient Saf       Date:  2017-12       Impact factor: 2.844

2.  In vivo testing of a novel blood pump for short-term extracorporeal life support.

Authors:  Nicholas R Teman; David S Demos; Benjamin S Bryner; Bradley Faliks; Emilia M Jahangir; Daniel E Mazur; Alvaro Rojas-Pena; Robert H Bartlett; Jonathan W Haft
Journal:  Ann Thorac Surg       Date:  2014-05-22       Impact factor: 4.330

Review 3.  Mechanical bridge to decision: what are the options for the management of acute refractory cardiogenic shock?

Authors:  Daniel Goldstein; Siyamek Neragi-Miandoab
Journal:  Curr Heart Fail Rep       Date:  2011-03

4.  Short- and long-term survival of patients transferred to a tertiary care center on temporary extracorporeal circulatory support.

Authors:  Jonathan W Haft; Francis D Pagani; Matthew A Romano; Christina L Leventhal; D Bradley Dyke; Jennifer C Matthews
Journal:  Ann Thorac Surg       Date:  2009-09       Impact factor: 4.330

5.  Position paper for the organization of ECMO programs for cardiac failure in adults.

Authors:  Darryl Abrams; A Reshad Garan; Akram Abdelbary; Matthew Bacchetta; Robert H Bartlett; James Beck; Jan Belohlavek; Yih-Sharng Chen; Eddy Fan; Niall D Ferguson; Jo-Anne Fowles; John Fraser; Michelle Gong; Ibrahim F Hassan; Carol Hodgson; Xiaotong Hou; Katarzyna Hryniewicz; Shingo Ichiba; William A Jakobleff; Roberto Lorusso; Graeme MacLaren; Shay McGuinness; Thomas Mueller; Pauline K Park; Giles Peek; Vin Pellegrino; Susanna Price; Erika B Rosenzweig; Tetsuya Sakamoto; Leonardo Salazar; Matthieu Schmidt; Arthur S Slutsky; Christian Spaulding; Hiroo Takayama; Koji Takeda; Alain Vuylsteke; Alain Combes; Daniel Brodie
Journal:  Intensive Care Med       Date:  2018-02-15       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.